Epigenetic therapy has been shown to regulate various components of the TME and enhance antitumor immunity.15 16 In this study, we found that KDM4C, a key enzyme in epigenetic modification, was directly involved in regulating antitumor immunity in lung cancer. This evidence concerns the gene KDM4C and lung carcinoma.